Pay in 4 interest-free payments of $7.35 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
These observations have been hypothesized to be due to a higher medication exposure among women, i.e., increased plasma concentration of the treatment due to their lower mean body weight
We help with weight management through regular check-ups and support
Retatrutide produced 28.7% weight loss at 68 weeks in the TRIUMPH-4 Phase 3 trial, compared to Tirzepatides 22.5% at 72 weeks in SURMOUNT-1
In medical weight loss, commonly used peptide classes include growth-hormonerelated peptides (like AOD9604 or tesamorelin), appetite- and glucose-regulating agents (such as GLP1 analogs), and others that influence insulin sensitivity, inflammation, and body composition
US$ 23.22
US$ 22.47
US$ 22.39
US$ 27.69
US$ 22.76
US$ 26.90
US$ 21.59
US$ 26.03
US$ 27.06
US$ 24.51
US$ 21.00
